28 related articles for article (PubMed ID: 38527692)
1. HK2 and LDHA upregulation mediate hexavalent chromium-induced carcinogenesis, cancer development and prognosis through miR-218 inhibition.
Wang L; Zhang RK; Sang P; Xie YX; Zhang Y; Zhou ZH; Wang KK; Zhou FM; Ji XB; Liu WJ; Qiu JG; Jiang BH
Ecotoxicol Environ Saf; 2024 Jul; 279():116500. PubMed ID: 38795416
[TBL] [Abstract][Full Text] [Related]
2. Lung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromium.
Beaver LM; Stemmy EJ; Constant SL; Schwartz A; Little LG; Gigley JP; Chun G; Sugden KD; Ceryak SM; Patierno SR
Toxicol Appl Pharmacol; 2009 Feb; 235(1):47-56. PubMed ID: 19109987
[TBL] [Abstract][Full Text] [Related]
3. Long-term exposure to hexavalent chromium inhibits expression of tumor suppressor genes in cultured cells and in mice.
Fan Y; Ovesen JL; Puga A
J Trace Elem Med Biol; 2012 Jun; 26(2-3):188-91. PubMed ID: 22613061
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ABHD11-AS1 interacts with SART3 and regulates CD44 RNA alternative splicing to promote lung carcinogenesis.
Wang PS; Liu Z; Sweef O; Xie J; Chen J; Zhu H; Zeidler-Erdely PC; Yang C; Wang Z
Environ Int; 2024 Mar; 185():108494. PubMed ID: 38364571
[TBL] [Abstract][Full Text] [Related]
5. Hexavalent chromium induces malignant transformation of human lung bronchial epithelial cells via ROS-dependent activation of miR-21-PDCD4 signaling.
Pratheeshkumar P; Son YO; Divya SP; Turcios L; Roy RV; Hitron JA; Wang L; Kim D; Dai J; Asha P; Zhang Z; Shi X
Oncotarget; 2016 Aug; 7(32):51193-51210. PubMed ID: 27323401
[TBL] [Abstract][Full Text] [Related]
6. Chronic Hexavalent Chromium Exposure Upregulates the RNA Methyltransferase METTL3 Expression to Promote Cell Transformation, Cancer Stem Cell-Like Property, and Tumorigenesis.
Wang Z; Uddin MB; Xie J; Tao H; Zeidler-Erdely PC; Kondo K; Yang C
Toxicol Sci; 2022 Apr; 187(1):51-61. PubMed ID: 35201342
[TBL] [Abstract][Full Text] [Related]
7. Suppression of miR-143 contributes to overexpression of IL-6, HIF-1α and NF-κB p65 in Cr(VI)-induced human exposure and tumor growth.
Wang L; Qiu JG; He J; Liu WJ; Ge X; Zhou FM; Huang YX; Jiang BH; Liu LZ
Toxicol Appl Pharmacol; 2019 Sep; 378():114603. PubMed ID: 31152816
[TBL] [Abstract][Full Text] [Related]
8. Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis.
Wang PS; Liu Z; Sweef O; Saeed AF; Kluz T; Costa M; Shroyer KR; Kondo K; Wang Z; Yang C
Cancer Lett; 2024 May; 589():216827. PubMed ID: 38527692
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
Proctor DM; Suh M; Campleman SL; Thompson CM
Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory effects of hexavalent chromium in the lung: A comprehensive review.
Kouokam JC; Meaza I; Wise JP
Toxicol Appl Pharmacol; 2022 Nov; 455():116265. PubMed ID: 36208701
[TBL] [Abstract][Full Text] [Related]
11. Impact of hexavalent chromium on mammalian cell bioenergetics: phenotypic changes, molecular basis and potential relevance to chromate-induced lung cancer.
Abreu PL; Ferreira LM; Alpoim MC; Urbano AM
Biometals; 2014 Jun; 27(3):409-43. PubMed ID: 24664226
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
